GenomeDx Achieves Significant Medicare Milestone for Decipher Prostate Biopsy Genomic Classifier

21 September 2018

GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced that Noridian GBA, a Medicare Administrative Contractor (MAC), has issued a draft local coverage determinati